[go: up one dir, main page]

MX2017010122A - Composiciones y metodos para determinar el pronostico de cancer de endometrio. - Google Patents

Composiciones y metodos para determinar el pronostico de cancer de endometrio.

Info

Publication number
MX2017010122A
MX2017010122A MX2017010122A MX2017010122A MX2017010122A MX 2017010122 A MX2017010122 A MX 2017010122A MX 2017010122 A MX2017010122 A MX 2017010122A MX 2017010122 A MX2017010122 A MX 2017010122A MX 2017010122 A MX2017010122 A MX 2017010122A
Authority
MX
Mexico
Prior art keywords
compositions
methods
endometrary
cancer
determining
Prior art date
Application number
MX2017010122A
Other languages
English (en)
Other versions
MX381948B (es
Inventor
J Arvai Kevin
Wang Yongbao
Jones Daniel
Original Assignee
Quest Diagnostics Invest Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quest Diagnostics Invest Llc filed Critical Quest Diagnostics Invest Llc
Publication of MX2017010122A publication Critical patent/MX2017010122A/es
Publication of MX381948B publication Critical patent/MX381948B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La presente invención proporciona métodos y composiciones para determinar el pronóstico en individuos con cáncer, en particular cáncer de endometrio. La presente invención también proporciona métodos para desarrollar y usar modelos predictivos que son útiles para determinar el pronóstico de cáncer de endometrio y otras enfermedades similares. La presente invención además proporciona métodos para determinar el estado de microsatélites usando secuenciación de nueva generación.
MX2017010122A 2015-02-06 2016-02-05 Composiciones y metodos para determinar el pronostico de cancer de endometrio. MX381948B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562113340P 2015-02-06 2015-02-06
US201562113990P 2015-02-09 2015-02-09
PCT/US2016/016799 WO2016127067A1 (en) 2015-02-06 2016-02-05 Compositions and methods for determining endometrial cancer prognosis

Publications (2)

Publication Number Publication Date
MX2017010122A true MX2017010122A (es) 2018-06-06
MX381948B MX381948B (es) 2025-03-13

Family

ID=56564751

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2017010122A MX381948B (es) 2015-02-06 2016-02-05 Composiciones y metodos para determinar el pronostico de cancer de endometrio.
MX2021000899A MX2021000899A (es) 2015-02-06 2017-08-04 Composiciones y metodos para determinar el pronostico de cancer de endometrio.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2021000899A MX2021000899A (es) 2015-02-06 2017-08-04 Composiciones y metodos para determinar el pronostico de cancer de endometrio.

Country Status (7)

Country Link
US (2) US20180094301A1 (es)
EP (2) EP3819389B1 (es)
CN (2) CN115094141A (es)
BR (1) BR112017016752A2 (es)
CA (1) CA2975737A1 (es)
MX (2) MX381948B (es)
WO (1) WO2016127067A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201614474D0 (en) 2016-08-24 2016-10-05 Univ Of Newcastle Upon Tyne The Methods of identifying microsatellite instability
AU2018254252A1 (en) * 2017-04-21 2019-11-21 The University Of British Columbia Stratification and prognosis of cancer
US10699802B2 (en) 2017-10-09 2020-06-30 Strata Oncology, Inc. Microsatellite instability characterization
CN108814592A (zh) * 2018-04-24 2018-11-16 哈尔滨工业大学 基于小波能量判定癫痫发作前脑电信号的方法及系统
EP3935193A1 (en) * 2019-03-06 2022-01-12 INSERM (Institut National de la Santé et de la Recherche Médicale) Method to diagnose a cmmrd
CN112037859B (zh) * 2020-09-02 2023-12-19 迈杰转化医学研究(苏州)有限公司 一种微卫星不稳定性的分析方法和分析装置

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO573697A0 (en) * 1997-03-20 1997-04-10 Prince Henry's Institute Of Medical Research Diagnosis of endometrial cancer
EP1522594A3 (en) * 2003-10-06 2005-06-22 Bayer HealthCare AG Methods and kits for investigating cancer
US20100196509A1 (en) * 2005-02-28 2010-08-05 Jonathan Braun Methods for Diagnosis and Treatment of Endometrial Cancer
JP5350369B2 (ja) * 2007-05-31 2013-11-27 ダコ デンマーク アクティーゼルスカブ 乳癌治療および予後におけるｅｓｒコピー数変化の利用方法
WO2011009114A2 (en) 2009-07-17 2011-01-20 The Translational Genomics Research Institute Methods and kits used in assessing cancer risk
US20110217701A1 (en) * 2010-03-03 2011-09-08 Carter Scott L Prognostic Marker for Endometrial Carcinoma
WO2013056178A2 (en) * 2011-10-14 2013-04-18 Foundation Medicine, Inc. Novel estrogen receptor mutations and uses thereof
CN103547683A (zh) * 2012-03-22 2014-01-29 耶鲁大学 Kras突变和肿瘤生物学

Also Published As

Publication number Publication date
MX381948B (es) 2025-03-13
CN115094141A (zh) 2022-09-23
MX2021000899A (es) 2021-03-31
WO2016127067A1 (en) 2016-08-11
EP3819389A1 (en) 2021-05-12
BR112017016752A2 (pt) 2018-04-10
EP3253891B1 (en) 2020-11-11
EP3253891A4 (en) 2018-09-19
CN107532208B (zh) 2022-07-05
US20180094301A1 (en) 2018-04-05
CA2975737A1 (en) 2016-08-11
EP3253891A1 (en) 2017-12-13
CN107532208A (zh) 2018-01-02
US20230193358A1 (en) 2023-06-22
EP3819389B1 (en) 2024-03-20

Similar Documents

Publication Publication Date Title
CL2021000717A1 (es) Constructos de anticuerpo para cd70 y cd3. divisional de solicitud 270-2018
MX2017010122A (es) Composiciones y metodos para determinar el pronostico de cancer de endometrio.
MX2017008421A (es) Métodos terapéuticos, diagnósticos y pronósticos para el cáncer de vejiga.
CO2018000882A2 (es) Constructos de anticuerpo para flt3 y cd3
BR112017020893A2 (pt) método para o tratamento de câncer
CR20170079A (es) Agentes de unión a cd123 y usos de estos
BR112017003414A2 (pt) composições compreendendo caseína e métodos para produzir as mesmas
MX2017003387A (es) Biomarcadores predictivos y para prognosis relacionados con terapia anti-angiogenetica de cancer colorrectal metastasico.
CR20170297A (es) Método para la cuantificación absoluta de péptidos cancerosos restringidos a hla que son procesados de forma natural
MX2016013239A (es) Tratamiento de cancer utilizando receptor quimerico de antigeno anti-cd19.
UY35385A (es) ?métodos y composiciones para el control de malezas?.
EA201400984A2 (ru) Способы и аппараты для прогнозирования риска рака предстательной железы и объема предстательной железы
MX387719B (es) Biomarcadores de la enfermedad del hígado graso no alcohólico (nafld) y la esteatohepatitis no alcohólica (nash) y usos de estos.
CO2017005773A2 (es) Composiciones, dispositivos, y métodos de pruebas de sensibilidad del ibs
EP3511422A3 (en) Methods and compositions for diagnosing, prognosing, and treating endometriosis
BR112016023238A2 (pt) processos de tratamento seletivo de asma usando antagonistas de il-13
GB2540702A (en) Nucleic acid processing of a nucleic acid fragment with a triazole linkage
BR112016017112A2 (pt) Composições de apilimod e métodos de uso das mesmas
MX2016001719A (es) Metodos y equipos para predecir el riesgo de tener una enfermedad o evento cardiovascular.
MX2017000840A (es) Metodo para predecir el resultado de un tratamiento con aflibercept de un paciente que se sospecha que padece un cancer.
EP3414650A4 (en) SOCIAL KEYBOARD
AR107786A1 (es) Métodos y composiciones para la detección y el diagnóstico de enfermedad renal y enfermedad periodontal
EA202091497A2 (ru) Генетические локусы, связанные с повышенной фертильностью у маиса
CL2015002705A1 (es) Anticuerpos anti-cd52.
CO2018007621A2 (es) Composiciones y métodos para evaluar el riesgo de ocurrencia de cáncer